Drug Trial Radar · NCT05878860
ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis
Last checked: Nov 19, 2026Latest source record: Sep 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
97
Planned (sponsor's estimate)
Start
Aug 22, 2023
Primary completion
Apr 2028
Study completion Apr 2033
Sponsor
- Lead sponsor
- Atsena Therapeutics Inc.Industry
- Sponsor type
- Industry
- First posted
- May 26, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 5 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the safety and efficacy of ATSN-201 in subjects ≥ 5 years of age with RS1-associated X-linked retinoschisis (XLRS).
Conditions
- X-linked Retinoschisis
Interventions
ATSN-201Biological
AAV.SPR-hGRK1-hRS1syn
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part A (Dose Escalation) and Part B (Dose Expansion): Safety and tolerability as assessed by dose-limiting toxicities and treatment-emergent adverse eventsTime frame: From baseline to week 52
- Part C (Phase 3, Randomized, Controlled) Effect of ATSN-201 on visual function.Time frame: From baseline to week 52
Locations
21 sites in 3 countries. Site status is shown where the registry gives one.
Associated Retina Consultants
Phoenix, Arizona · Recruiting
Shiley Eye Institute
La Jolla, California · Not yet recruiting
Children's Hospital of Los Angeles
Los Angeles, California · Recruiting
Stanford University
Palo Alto, California · Not yet recruiting
UC San Francisco
San Francisco, California · Recruiting
Bascom Palmer Eye Institute
Miami, Florida · Recruiting
Massachusetts Eye and Ear
Boston, Massachusetts · Recruiting
Boston Children's Hospital
Boston, Massachusetts · Not yet recruiting
University of Michigan
Ann Arbor, Michigan · Recruiting
Mayo Clinic
Rochester, Minnesota · Recruiting
Columbia University
New York, New York · Recruiting
Flaum Eye Institute, University of Rochester
Rochester, New York · Not yet recruiting
Duke University
Durham, North Carolina · Recruiting
Oregon Health Sciences University
Portland, Oregon · Recruiting
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania · Recruiting
Retina Foundation of the Southwest
Dallas, Texas · Recruiting
Moran Eye Center
Salt Lake City, Utah · Recruiting
University of Wisconsin
Madison, Wisconsin · Recruiting
The Hospital for Sick Children
Toronto, Ontario, Canada · Not yet recruiting
McGill University (MUHC)
Montreal, Quebec, Canada · Not yet recruiting
Oxford Eye Hospital
Oxford, England, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.